SCHEMBL5215323

SCHEMBL5215323

Cn1cccc1C(=O)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.56
MEN1 O00255 1/20 0.56
LMNA P02545 1/20 0.56
MAPT P10636 1/20 0.56
ALOX12 P18054 1/20 0.56
RECQL P46063 1/20 0.56
KMT2A Q03164 1/20 0.56
SMN1; SMN2 Q16637 2/20 0.53
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53
PKM P14618 1/20 0.53
NFKB1 P19838 1/20 0.53
NFKB2 Q00653 1/20 0.53
RELA Q04206 1/20 0.53
HSD17B10 Q99714 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
POLB P06746 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL526662 0.85 SMN1; SMN2 (0.58) ALDH1A1MEN1MAPTKMT2ASMN1; SMN2
SCHEMBL5216279 0.85 LMNA (0.54) ALDH1A1LMNAMAPTSMN1; SMN2NPC1
Acetic Acid SCHEMBL25348402 0.84 KDM4E (0.49) ALDH1A1MEN1LMNAMAPTALOX12
SCHEMBL9013254 0.83 MEN1 (0.50) ALDH1A1MEN1LMNAMAPTALOX12
SCHEMBL6331530 0.83 SMN1; SMN2 (0.46) ALDH1A1MEN1LMNAMAPTALOX12
SCHEMBL5223686 0.83 SMN1; SMN2 (0.62) ALDH1A1MEN1MAPTRECQLKMT2A
Hydrochloric Acid SCHEMBL5219486 0.82 MAPT (0.51) MEN1LMNAMAPTKMT2ASMN1; SMN2
SCHEMBL6957332 0.80 RAB9A (0.50) ALDH1A1MEN1LMNAMAPTKMT2A
Propionic Acid SCHEMBL27527775 0.80 CXCL8 (0.51) ALDH1A1MEN1LMNAMAPTALOX12
SCHEMBL11245998 0.79 SMN1; SMN2 (0.54) ALDH1A1KMT2ASMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-55115868-A None JP disclosed
EP-1458386-B1 AROYL PYRROLE HETEROERYL AND METHANOLS USEFUL FOR TREATING A CENTRAL NERVOUS SYSTEM DISORDER ORTHO MCNEIL PHARM INC (US) 2007-04-18 EP disclosed
US-20050148636-A1 Useful aroyl pyrrole heteroaryl methanones and methanols JANSSEN PHARMACEUTICA, N.V. (BE) 2005-07-07 US disclosed
US-6897319-B2 Useful aroyl pyrrole heteroaryl methanones and methanols ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2005-05-24 US disclosed
EP-1458386-A1 AROYL PYRROLE HETEROERYL AND METHANOLS USEFUL FOR TREATING A CENTRAL NERVOUS SYSTEM DISORDER Ortho-McNeil Pharmaceutical, Inc. (US) 2004-09-22 EP disclosed
US-20040058980-A1 Useful aroyl pyrrole heteroaryl methanones and methanols ORTHO-MCNEIL PHARMACEUTICALS, INC. 2004-03-25 US disclosed
US-20030181481-A1 Useful aroyl pyrrole heteroaryl methanones and methanols ORTHO-MCNEIL PHARMACEUTICAL, INC. 2003-09-25 US disclosed
WO-2003057219-A1 AROYL PYRROLE HETEROERYL AND METHANOLS USEFUL FOR TREATING A CENTRAL NERVOUS SYSTEM DISORDER ORTHO-MCNEIL PHARMACEUTICAL INC. (US) 2003-07-17 WO disclosed
WO-2003057147-A2 USEFUL AROYL PYRROLE HETEROARYL METHANONES AND METHANOLS ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2003-07-17 WO disclosed
WO-1995013266-A1 ACYLPYRROLE-ALKANOIC ACIDS AND INDOLE-2-ALKANOIC ACIDS PLUS THEIR DERIVATIVES FOR USE AS INHIBITORS OF PHOSPHOLIPASE A¿2? MERCKLE GMBH CHEM.-PHARM. FABRIK (DE) 1995-05-18 WO disclosed
EP-0231996-B1 NOVEL AMINO ACID DERIVATIVES NOVO NORDISK A/S (DK) 1993-10-06 EP disclosed
US-4931450-A Amino acid derivatives NOVO INDUSTRI A/S (DK) 1990-06-05 US disclosed
EP-0231996-A2 Novel amino acid derivatives NOVO NORDISK A/S (DK) 1987-08-12 EP disclosed
JP-S55115868-A BETA,BETA,BETA-TRIHALO-ALPHA-HYDROXYETHYL SUBSTITUTED-2-AROYL PYRROLE DERIVATIVE SAGAMI CHEM RES CENTER 1980-09-06 JP disclosed
US-4002643-A REARRANGING WITH A STRONG, ANHYDROUS, NON-OXIDIZING ACID MCNEIL LABORATORIES, INC. (US) 1977-01-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050148636-A1 Useful aroyl pyrrole heteroaryl methanones and methanols CYP11B2, NLN, CNR2 ALDH1A1 1382/4885MEN1 706/4885LMNA 3871/4885
US-20040058980-A1 Useful aroyl pyrrole heteroaryl methanones and methanols CYP11B2, NLN, CNR2 ALDH1A1 1382/4885MEN1 706/4885LMNA 3871/4885
US-20030181481-A1 Useful aroyl pyrrole heteroaryl methanones and methanols CYP11B2, NLN, CNR2 ALDH1A1 1382/4885MEN1 706/4885LMNA 3871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.